Edition:
United States

Redhill Biopharma Ltd (RDHL.OQ)

RDHL.OQ on NASDAQ Stock Exchange Capital Market

4.83USD
15 Dec 2017
Change (% chg)

$0.03 (+0.62%)
Prev Close
$4.80
Open
$4.79
Day's High
$4.88
Day's Low
$4.73
Volume
31,114
Avg. Vol
41,614
52-wk High
$11.53
52-wk Low
$4.30

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.54 December 17 Dec 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 0
(2) OUTPERFORM 4 4 4 3
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.00 2.00 2.00 2.00

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 4 2.17 3.00 1.80 8.13
Quarter Ending Mar-18 2 2.65 3.50 1.80 --
Year Ending Dec-17 5 4.94 7.50 3.80 7.22
Year Ending Dec-18 5 36.84 113.90 8.80 42.38
Earnings (per share)
Quarter Ending Dec-17 3 -0.54 -0.48 -0.65 0.13
Quarter Ending Mar-18 1 -0.51 -0.51 -0.51 --
Year Ending Dec-17 2 -2.41 -2.13 -2.70 -2.20
Year Ending Dec-18 3 -0.57 2.04 -1.94 1.14

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 1.13 1.52 0.39 34.19
Quarter Ending Jun-17 0.22 0.48 0.26 116.88
Quarter Ending Mar-17 0.00 0.00 0.00 0.00
Quarter Ending Dec-16 0.03 0.10 0.08 300.00
Quarter Ending Sep-16 0.00 0.00 0.00 0.00
Earnings (per share)
Quarter Ending Sep-17 -0.63 0.09 0.72 -114.21
Quarter Ending Jun-17 -0.57 -0.60 0.03 -4.35
Quarter Ending Mar-17 -0.57 -0.50 0.07 -12.79
Quarter Ending Dec-16 -0.67 -0.60 0.07 -10.00
Quarter Ending Sep-16 -0.58 -0.70 0.12 -20.69

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 2.17 2.17 1.84 1.74 8.13
Quarter Ending Mar-18 2.65 2.65 3.45 3.45 --
Year Ending Dec-17 4.94 4.94 5.90 5.70 7.22
Year Ending Dec-18 36.84 36.84 38.44 37.94 42.38
Earnings (per share)
Quarter Ending Dec-17 -0.54 -0.54 -0.60 -0.62 0.13
Quarter Ending Mar-18 -0.51 -0.51 -0.51 -0.51 --
Year Ending Dec-17 -2.41 -2.41 -2.43 -2.39 -2.20
Year Ending Dec-18 -0.57 -0.57 -0.46 -0.54 1.14

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-17 0 0 1 1
Quarter Ending Mar-18 0 0 0 1
Year Ending Dec-17 0 0 1 2
Year Ending Dec-18 0 0 0 1
Earnings
Quarter Ending Dec-17 0 0 1 0
Quarter Ending Mar-18 0 0 0 0
Year Ending Dec-17 0 0 0 0
Year Ending Dec-18 0 0 0 1